Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22087077 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children
Conditions: Fever;   Malaria
Interventions: Drug: amodiaquine-artesunate (ASAQ);   Drug: dihydroartemisinin-piperaquine (DHAPQ);   Drug: artemether-lumefantrine (AL);   Drug: Lapdap (Chlorproguanil-Dapsone) + artesunate (AS)

Indicates status has not been verified in more than two years